Seedlabs

CDS Flag: A Daydreaming-Distinction Screen for ADHD Evaluations

A screening tool that helps doctors spot quiet, daydreaming patients who might be missed by standard ADHD tests.

A clinician-facing screening module that scores cognitive disengagement syndrome (CDS) symptoms — excessive daydreaming, mental confusion, hypoactivity — on a separate axis from standard ADHD scales during an ADHD evaluation, so quiet, daydreaming patients are not simply labeled inattentive ADHD.

MedicineAttention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity DisorderPediatric and adult ADHD diagnostic services / mental health assessment

Concept

A software module that bolts a validated CDS rating scale onto existing ADHD assessment workflows in pediatric and adult clinics. When a patient is referred for inattention, the module administers CDS items covering the three hallmark clusters — excessive daydreaming, mental confusion, and hypoactivity — alongside the standard ADHD scales, then generates a two-axis report: ADHD symptom severity vs. CDS symptom severity. Patients with elevated CDS but low ADHD scores are flagged for a different follow-up path than ADHD-inattentive cases. The single wedge is at the point of assessment: separate the "disengaged daydreamer" from the "ADHD inattentive" patient so the right people get the right follow-up instead of being folded into a diagnosis their profile doesn't fit.

Why now

Paper [0] establishes that CDS is a symptom set distinct from ADHD and other psychopathology dimensions and independently associated with functional outcomes — meaning an ADHD-only evaluation systematically misses an impairment-relevant construct. Critically, [0] also reports that psychometrically rigorous CDS assessment tools now exist, so the differentiation is measurable with validated instruments rather than requiring new science. Older paper [1] documents the 2021 international work group consensus that renamed sluggish cognitive tempo to CDS and prioritized assessment as a key research direction, signaling the field has consolidated around a stable construct and terminology that a vendor can build against. The product is deliberately a scoring-and-flagging tool, not a new diagnostic claim — it operationalizes what the review shows is already established.

Written by GLM · 10 Oct 2026

AI assessment

Backed by 2 papers88

A focused clinical tool that operationalizes a validated, distinct symptom set (CDS) to prevent misdiagnosis of ADHD-inattentive type, offering a clear wedge into existing diagnostic workflows.

Evidence strength
5/5
The idea relies on a consensus of an international work group and specific, validated 15-item scales mentioned in the full text, making the transition from research to tool highly direct.
Market pull
4/5
Clinicians and diagnostic centers have a strong incentive to increase diagnostic precision to avoid ineffective treatments, though the willingness to pay for a 'module' versus a full platform varies.
Novelty & moat
3/5
While similar to other comorbidity tools in the catalog, it focuses on a specific, newly renamed construct (CDS) rather than general comorbidity, providing a distinct clinical value proposition.
Feasibility
5/5
The product is essentially a digital implementation of an existing validated scale and a two-axis reporting logic, requiring minimal technical R&D.
Wedge clarity
5/5
The wedge is extremely sharp: a specific screening step during the ADHD evaluation to differentiate 'daydreamers' from 'inattentive' patients.
Simplicity / focus
5/5
The idea avoids 'platform creep' and focuses solely on a scoring-and-flagging module for a single clinical purpose.

Scored by Gemma 4 · 10 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Who benefits

  • Qbtechcompany

    Makes QbTest, the objective ADHD test used in clinics; its activity and attention measurement under-detects the hypoactive, daydreaming profile, so a validated CDS rating module would let them flag exactly the patients their hardware tends to miss.

  • Runs online ADHD assessments at scale in the US; adding a CDS screen to their intake would reduce misclassification of inattentive adults and differentiate the quality of their diagnostic reports.

  • Publishes widely used behavior rating scales; a CDS module extends their ADHD assessment line to cover the newly consolidated construct using already-validated items.

  • CHADDorganization

    National ADHD support organization; many members — especially inattentive-presenting adults and parents of quiet, daydreaming children — would finally get an accurate explanation and support pathway when standard ADHD criteria don't fit.

Research it builds on

  1. Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement Syndrome
    Stephen P. Becker, Erik G. Willcutt, Daniel R. Leopold et al. · 2022 · 172 citations
    All ideas from this paper →
  2. Cognitive disengagement syndrome: A construct at the crossroads.
    Stephen P. Becker · 2025 · 44 citations
    All ideas from this paper →
Leave feedback
feasibility